Skip to content

Outset Medical, Inc. OM Enterprise value

Enterprise value at other companies

Baxter International logo
Baxter InternationalBAX
$6.88B-55.6%
DaVita logo
DaVitaDVA
$22.88B-5.5%
Medtronic logo
MedtronicMDT
$131.22B-3.2%
Haemonetics logo
HaemoneticsHAE
$3.65B-12.5%
CorMedix logo
CorMedixCRMD
$774.78M+71.7%
Teladoc Health logo
Teladoc HealthTDOC
$263.76M-66.3%

Other financials

Income statement

See full
Revenue$27.9M-6.3%
Gross profit$12.1M+9.3%
Operating income-$16.9M-3.2%
Net income-$19.0M+26.4%
EPS (diluted)-$1.03+71.9%

Balance sheet

See full
Cash & equivalents$30.6M-59.7%
Total debt$101.6M+3.5%
Total equity$111.7M-34.3%
Total assets$249.5M-17.2%

Cash flow

See full
Operating cash flow-$12.8M+50.0%
CapEx$65.0K-47.2%
Free cash flow-$12.9M+49.9%

Valuation

See full
Market cap$80.08M-77.6%
P/S0.7×-2.3×

Profitability

See full
Gross margin40.6%+4.7pp
Operating margin-57.2%-12.9pp
Net margin-63.7%-16.7pp
FCF margin-29.1%-11.5pp

Returns & leverage

See full
Return on equity-53.2%-14.8pp
Debt / equity0.9×+0.3×
Current ratio6.3×-2.1×

Where this comes from

Calculated from Outset Medical, Inc.’s reported figures.

The official record: Outset Medical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Outset Medical, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Outset Medical, Inc.'s enterprise value?
Outset Medical, Inc. (OM) reported enterprise value of $141.37M in Q1 2026.
How has Outset Medical, Inc.'s enterprise value changed year-over-year?
Outset Medical, Inc.'s enterprise value decreased by 35.2% year-over-year, from $218M to $141.37M.
What is the long-term trend for Outset Medical, Inc.'s enterprise value?
Over 5 years (2020 to 2025), Outset Medical, Inc.'s enterprise value has grown at a -59.1% compound annual growth rate (CAGR), from $11.72B to $133.59M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.